Literature DB >> 3165637

The elastogenic effect of recombinant transforming growth factor-beta on porcine aortic smooth muscle cells.

J M Liu1, J M Davidson.   

Abstract

Transforming growth factor-beta, a peptide growth factor, is known to be a multifunctional regulator of cellular activity. The effect of this growth factor on extracellular matrix formation is well established, but its effects on elastin, a critical component of lung, skin, and blood vessels are unknown. In the present study, by use of an Enzyme-Linked Immunoassay method, we found that transforming growth factor-beta strongly increased elastin production in cultured porcine aortic smooth muscle cells. In a dosage-dependent study, 1.0-10.0 ng/ml transforming growth factor-beta promoted elastin production 2-3 fold. In a time-dependent study, at least an 8 h pre-treatment with 10.0 ng/ml transforming growth factor-beta was required for sustained increases in elastin production. The effects of transforming growth factor-beta on cultured aortic smooth muscle cells suggest that this cytokine may be an important mediator of elastin formation during atherosclerosis and hypertension.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3165637     DOI: 10.1016/0006-291x(88)90224-0

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  22 in total

1.  TGF-beta 1 is a potential regulator of vaginal tropoelastin production.

Authors:  Peter Takacs; Yanping Zhang; Sujata Yavagal; Keith Candiotti; Nahida Chakhtoura; Carlos A Medina
Journal:  Int Urogynecol J       Date:  2011-11-09       Impact factor: 2.894

2.  Cellular Self-Assembly with Microsphere Incorporation for Growth Factor Delivery Within Engineered Vascular Tissue Rings.

Authors:  Hannah A Strobel; Anna D Dikina; Karen Levi; Loran D Solorio; Eben Alsberg; Marsha W Rolle
Journal:  Tissue Eng Part A       Date:  2016-12-06       Impact factor: 3.845

Review 3.  Mesenchymal stem cells for treatment of aortic aneurysms.

Authors:  Aika Yamawaki-Ogata; Ryotaro Hashizume; Xian-Ming Fu; Akihiko Usui; Yuji Narita
Journal:  World J Stem Cells       Date:  2014-07-26       Impact factor: 5.326

Review 4.  VLA-4 and lymphocyte trafficking in immune-inflammatory states: novel therapeutic approaches in allograft arteriopathy.

Authors:  S Molossi; M Rabinovitch
Journal:  Springer Semin Immunopathol       Date:  1995

5.  TGF-beta antibodies: a novel treatment for pulmonary fibrosis?

Authors:  G J Laurent; R K Coker; R J McAnulty
Journal:  Thorax       Date:  1993-10       Impact factor: 9.139

6.  Transforming growth factor-beta activity in sheep lung lymph during the development of pulmonary hypertension.

Authors:  E A Perkett; R M Lyons; H L Moses; K L Brigham; B Meyrick
Journal:  J Clin Invest       Date:  1990-11       Impact factor: 14.808

Review 7.  A cytokine axis regulates elastin formation and degradation.

Authors:  Erin P Sproul; W Scott Argraves
Journal:  Matrix Biol       Date:  2012-11-13       Impact factor: 11.583

8.  Interleukin 10 up-regulates elastin gene expression in vivo and in vitro at the transcriptional level.

Authors:  S Reitamo; A Remitz; K Tamai; I Ledo; J Uitto
Journal:  Biochem J       Date:  1994-09-01       Impact factor: 3.857

9.  Neointimal macrophages colocalize with extracellular matrix gene expression in human atherosclerotic pulmonary arteries.

Authors:  M J Liptay; W C Parks; R P Mecham; J Roby; L R Kaiser; J D Cooper; M D Botney
Journal:  J Clin Invest       Date:  1993-02       Impact factor: 14.808

10.  Expression of transforming growth factor-beta 1 is increased in human vascular restenosis lesions.

Authors:  S Nikol; J M Isner; J G Pickering; M Kearney; G Leclerc; L Weir
Journal:  J Clin Invest       Date:  1992-10       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.